Medical Marijuana 411 values providing our readers with information about the latest cannabis related topics for educational purposes and not for the intention of advocacy. This is not an advocacy-based organization. For ailment specific questions, please consult your primary care physician.
Presidential candidate Joe Biden recently rehashed one of the most common cannabis myths. He called cannabis a “gateway drug” during a campaign event.
A study, published at the beginning of 2019, suggested that that CBD autism treatment in children may be successful in relieving disruptive symptoms.
Dr. Raphael Mechoulam has continued his cannabis research and made discoveries that help to create an understanding of the benefits of the cannabis plant.
In 2019, Pennsylvania added anxiety disorders to the list of medical cannabis qualifying conditions, making cannabis available to those with anxiety.
A number of studies have researched if CBD has potential as a treatment for depression and other mental health ailments. The results are promising.
A new large scale study about the effects of using cannabis during pregnancy has been released by the Journal of the American Medical Association.
New research is emerging that CBD may be part of the next wave of antibiotics used to treat bacterial infections, including superbugs like MRSA.
Many veterans believe cannabis to be a safer alternative to alcohol and addictive drugs, but many are not receiving medical advice related to cannabis.
The popularity of CBD has grown due in large part to research that the compound has a number of medicinal uses and relatively few negative side effects.